Mohammad Alzrigat

Genome-wide profiling of histone H3 lysine 27 and lysine 4 trimethylation in multiple myeloma reveals the importance of Polycomb gene targeting and highlights EZH2 as a potential therapeutic target

Prasoon Agarwal, Mohammad Alzrigat, Alba Atienza Párraga et al. · Oncotarget · 2016 · 72 citations · Full text

Life Sciences, Genetics, Oncology +17

PML promotes MHC class II gene expression by stabilizing the class II transactivator

Tobias Ulbricht, Mohammad Alzrigat, Almut Horch et al. · The Journal of Cell Biology · 2012 · 67 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +16

EZH2 inhibition in multiple myeloma downregulates myeloma associated oncogenes and upregulates microRNAs with potential tumor suppressor functions

Mohammad Alzrigat, Alba Atienza Párraga, Prasoon Agarwal et al. · Oncotarget · 2016 · 53 citations · Full text

Medicine, Molecular Biology, Oncology +17

MYC Inhibition Halts Metastatic Breast Cancer Progression by Blocking Growth, Invasion, and Seeding

Daniel Massó-Vallés, Marie-Ève Beaulieu, Toni Jauset et al. · Cancer Research Communications · 2022 · 32 citations · Full text

Medicine, Cancer Biology, Oncology +17

The polycomb group protein BMI-1 inhibitor PTC-209 is a potent anti-myeloma agent alone or in combination with epigenetic inhibitors targeting EZH2 and the BET bromodomains

Mohammad Alzrigat, Alba Atienza Párraga, Muntasir Mamun Majumder et al. · Oncotarget · 2017 · 27 citations · Full text

Medicine, Cancer Biology, Oncology +17